Fukuda Denshi (6960) Q3 2026 earnings summary

Executive summary

• Net sales for the third quarter were ¥98,857 million, a 0.5% decrease year-over-year, with operating profit down 5.7% to ¥16,400 million and profit attributable to owners of parent down 5.2% to ¥11,726 million.

• Comprehensive income rose 32.3% year-over-year to ¥15,038 million, reflecting gains in other comprehensive income.

• The business environment remains uncertain due to rising resource prices and global trade frictions, but the medical industry is advancing digitalization and regional healthcare networks.

Financial highlights

• Gross profit for the quarter was ¥53,217 million, up from ¥52,266 million year-over-year.

• Earnings per share for the quarter were ¥425.16, slightly down from ¥429.25 in the prior year.

• Total assets decreased to ¥215,968 million, mainly due to a reduction in cash and deposits.

• Net assets stood at ¥181,533 million, with a shareholders' equity ratio of 84.1%.

Outlook and guidance

• Full-year forecast remains unchanged: net sales of ¥137,000 million (+1.4% YoY), operating profit of ¥24,000 million (+7.2%), and profit attributable to owners of parent of ¥17,000 million (+8.6%).

• Earnings per share for the full year is projected at ¥617.78, not factoring in the impact of the planned treasury share acquisition.